Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FWHJ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,924
Award facts
- Contract value 100% obligated
- $12,923.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency awarded a $12,923.56 delivery order to AmerisourceBergen Drug Corp for the supply of Wegovy 1.7 mg/0.75 mL pens. This is a firm fixed-price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania facility and an ultimate completion date of January 13, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. The award represents a single task order executed under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999999 billion through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order for Wegovy, a GLP-1 receptor agonist medication used in diabetes and weight management treatment, reflects the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military healthcare systems. The rapid completion timeline—with award and ultimate completion dates only one day apart—suggests this represents a small, time-sensitive supply replenishment. As a non-set-aside competitive award, the contract demonstrates AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements on an open basis through its established relationship with DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FWHJ6?
SPE2DR26FWHJ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FWHJ6 worth?
The government has obligated $12,924 on SPE2DR26FWHJ6.
Is contract SPE2DR26FWHJ6 an order under another contract?
Yes. SPE2DR26FWHJ6 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWHJ6 competed?
The extent of competition for SPE2DR26FWHJ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award